MedPath

武汉钧安制药有限公司

Ownership
-
Established
1999-04-09
Employees
-
Market Cap
-
Website
www.jajt.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:10

Drug Approvals

再造丸

Approval Number
国药准字Z42020936
Approval Date
Dec 15, 2021
NMPA

大活络丸

Approval Number
国药准字Z42020927
Approval Date
Dec 15, 2021
NMPA

Paracetamol, Caffein, Atificial Cow-bezoar and chlorphenamine Maleate capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H42022777
Approval Date
Jul 1, 2021
NMPA

Pediatric Compound Ephedrine Hydrochloride and Balloonflower Syrup

Product Name
小儿复方麻黄碱桔梗糖浆
Approval Number
国药准字H20067146
Approval Date
Jun 2, 2021
NMPA

Troxerutin Oral Solution

Product Name
曲克芦丁口服溶液
Approval Number
国药准字H20067145
Approval Date
Apr 25, 2021
NMPA

Rubidate Tablets

Product Name
茜草双酯片
Approval Number
国药准字H20055824
Approval Date
Sep 8, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H20055818
Approval Date
Sep 8, 2020
NMPA

Hymecromone Capsules

Product Name
羟甲香豆素胶囊
Approval Number
国药准字H20055821
Approval Date
Sep 8, 2020
NMPA

愈肝龙胶囊

Approval Number
国药准字Z20100031
Approval Date
Apr 15, 2020
NMPA

澳力宝牌奥立欣胶囊

Approval Number
国食健字G20060229
Approval Date
Feb 24, 2006
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.